SCHEMBL2853043

SCHEMBL2853043

C=CCc1ccc(C2CC3CCC(CC=C)CCC3C2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.34
ALDH1A1 P00352 2/20 0.34
TP53 P04637 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
ALOX12 P18054 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MAPT P10636 2/20 0.31
CYP1A2 P05177 1/20 0.31
XDH P47989 1/20 0.31
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30
ALDH2 P05091 1/20 0.30
GAA P10253 1/20 0.30
GABRA1 P14867 1/20 0.30
AKR1B1 P15121 1/20 0.30
HPGD P15428 1/20 0.30
CNR1 P21554 1/20 0.30
CNR2 P34972 1/20 0.30
PPARG P37231 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10423236 0.89 ESR2 (0.37) CYP3A4ALDH1A1TP53ALOX15TSHR
SCHEMBL9508996 0.89 ESR2 (0.37) CYP3A4ALDH1A1TP53ALOX15TSHR
SCHEMBL9297464 0.89 ESR2 (0.37) CYP3A4ALDH1A1TP53ALOX15TSHR
SCHEMBL3187714 0.88 CYP3A4 (0.34) CYP3A4ALDH1A1TP53ALOX15TSHR
SCHEMBL9297253 0.87 ESR2 (0.40) CYP3A4ALDH1A1TP53ALOX15TSHR
SCHEMBL11014791 0.87 ESR2 (0.40) CYP3A4ALDH1A1TP53ALOX15TSHR
SCHEMBL2853667 0.83 SLC6A2 (0.35)
SCHEMBL2857117 0.79 SLC6A2 (0.33) MAPT
SCHEMBL2857519 0.79 HRH3 (0.38)
SCHEMBL10904861 0.79 ESR2 (0.43) CYP3A4ALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100264368-A1 LIQUID CRYSTAL MOLECULES COMPRISING HYDROAZULENE STRUCTURES TETRAGON-CHEMIE AG (LI) 2010-10-21 US disclosed
EP-1896552-B1 LIQUID CRYSTAL MOLECULES COMPRISING HYDROAZULENE STRUCTURES TETRAGON CHEMIE AG (LI) 2010-05-19 EP disclosed
EP-1896552-A1 LIQUID CRYSTAL MOLECULES COMPRISING HYDROAZULENE STRUCTURES Tetragon-Chemie AG (LI) 2008-03-12 EP disclosed
WO-2006136345-A1 LIQUID CRYSTAL MOLECULES COMPRISING HYDROAZULENE STRUCTURES TETRAGON-CHEMIE AG (LI) 2006-12-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100264368-A1 LIQUID CRYSTAL MOLECULES COMPRISING HYDROAZULENE STRUCTURES FLI1, F12, GTF2I CYP3A4 2421/4885ALDH1A1 265/4885TP53 538/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.